| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213520 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 9 Pages |
Abstract
Both TMT and RC result in good long-term QOL outcomes in MIBC survivors, supporting TMT as a good alternative to RC for selected patients. Whether TMT leads to superior QOL requires prospective validation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kimberley S. MD, MPH, Angela B. MD, MS, Alec BS, Rebecca BS, Andrzej PhD, Jed-Sian MD, Jonathan MPH, Michael R. AB, Matthew E. MD, MS, Adam S. MD, MPH, Richard J. MD, PhD, Anthony L. MD, Ronald C. MD, MPH, William U. MD, FACR, FASTRO, Matthew I. MD,